Ventricular tachycardia

Last updated: June 18, 2025

Ventricular tachycardia

571 pharm 2

571 pharm 2

Autosomal trisomies: Pathology review
Gout
Down syndrome (Trisomy 21)
DNA damage and repair
Inheritance patterns
DNA replication
Selective permeability of the cell membrane
Cell cycle
Breast cancer: Pathology review
Endometrial hyperplasia and cancer: Clinical
Lung cancer
Colorectal polyps and cancer: Pathology review
Oral cancer
Testicular cancer
Metaplasia and dysplasia
Hypertension: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Acute respiratory distress syndrome
Angina pectoris
Aortic valve disease
Arterial disease
Asthma
Atrial septal defect
Bronchiectasis
Chronic bronchitis
Chronic venous insufficiency
Coarctation of the aorta
Deep vein thrombosis
Emphysema
Endocarditis
Gas exchange in the lungs, blood and tissues
Heart failure
Mitral valve disease
Myocardial infarction
Patent ductus arteriosus
Pericarditis and pericardial effusion
Peripheral artery disease
Pleural effusion
Pneumonia
Pulmonary edema
Restrictive lung diseases
Shock
Stroke volume, ejection fraction, and cardiac output
Tetralogy of Fallot
Stable angina
Unstable angina
Prinzmetal angina
Coronary steal syndrome
Subclavian steal syndrome
Aneurysms
Aortic dissection
Vasculitis
Behcet's disease
Kawasaki disease
Hypertension
Hypertensive emergency
Renal artery stenosis
Cushing syndrome
Conn syndrome
Pheochromocytoma
Polycystic kidney disease
Hypotension
Orthostatic hypotension
Abetalipoproteinemia
Familial hypercholesterolemia
Hypertriglyceridemia
Hyperlipidemia
Thrombophlebitis
Lymphedema
Lymphangioma
Vascular tumors
Human herpesvirus 8 (Kaposi sarcoma)
Angiosarcomas
Persistent truncus arteriosus
Transposition of the great vessels
Total anomalous pulmonary venous return
Hypoplastic left heart syndrome
Ventricular septal defect
Atrial flutter
Atrial fibrillation
Premature atrial contraction
Atrioventricular nodal reentrant tachycardia (AVNRT)
Wolff-Parkinson-White syndrome
Ventricular tachycardia
Brugada syndrome
Premature ventricular contraction
Long QT syndrome and Torsade de pointes
Ventricular fibrillation
Atrioventricular block
Bundle branch block
Pulseless electrical activity
Tricuspid valve disease
Pulmonary valve disease
Dilated cardiomyopathy
Restrictive cardiomyopathy
Hypertrophic cardiomyopathy
Cor pulmonale
Myocarditis
Rheumatic heart disease
Cardiac tamponade
Dressler syndrome
Cardiac tumors
Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Atherosclerosis and arteriosclerosis: Pathology review
Coronary artery disease: Pathology review
Peripheral artery disease: Pathology review
Valvular heart disease: Pathology review
Cardiomyopathies: Pathology review
Heart failure: Pathology review
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Heart blocks: Pathology review
Aortic dissections and aneurysms: Pathology review
Pericardial disease: Pathology review
Endocarditis: Pathology review
Shock: Pathology review
Vasculitis: Pathology review
Cardiac and vascular tumors: Pathology review
Dyslipidemias: Pathology review
Dementia: Pathology review
Anxiety disorders: Clinical
Arteriovenous malformation
Bipolar and related disorders
Cauda equina syndrome
Cranial nerves
Seizures and epilepsy
Generalized anxiety disorder
Headaches: Pathology review
Huntington disease
Ischemic stroke
Major depressive disorder
Meningitis
Migraine
Multiple sclerosis
Myasthenia gravis
Panic disorder
Parkinson disease
Stroke: Clinical
Alzheimer disease
Diabetes mellitus: Pathology review
Abnormal uterine bleeding: Clinical
Adrenocorticotropic hormone
Chlamydia trachomatis
Cortisol
Endometriosis
Glucagon
Glucocorticoids
Herpes simplex virus
HIV (AIDS)
Hyperthyroidism: Pathology review
Hypothyroidism: Pathology review
Hypothyroidism
Insulin
Neisseria gonorrhoeae
Pelvic inflammatory disease
Polycystic ovary syndrome
Primary adrenal insufficiency
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Testosterone
Thyroid hormones
Benign prostatic hyperplasia
Anemia of chronic disease
Chronic leukemia
Coagulation disorders: Pathology review
Disseminated intravascular coagulation
Factor V Leiden
Hemophilia
Hodgkin lymphoma
Non-Hodgkin lymphoma
Hypocalcemia
Hypokalemia
Inflammation
Innate immune system
Introduction to the immune system
Iron deficiency anemia
Leukemias: Pathology review
Platelet disorders: Pathology review
Sickle cell disease (NORD)
Type IV hypersensitivity
Vaccinations
Acute cholecystitis
Acute pancreatitis
Acute pyelonephritis
Alcohol-associated liver disease
Appendicitis
Autoimmune hepatitis
Biliary colic
Bowel obstruction
Celiac disease
Chronic cholecystitis
Chronic pyelonephritis
Chronic pancreatitis
Cirrhosis
Congenital disorders: Clinical
Crohn disease
Gastroesophageal reflux disease (GERD)
Irritable bowel syndrome
Lower urinary tract infection
Nephrotic syndromes: Pathology review
Peptic ulcer
Renal failure: Pathology review
Ulcerative colitis
Urinary tract infections: Pathology review
Viral hepatitis
Acne vulgaris
Atopic dermatitis
Back pain: Pathology review
Bone disorders: Pathology review
Burns
Osteoarthritis
Osteoporosis
Paget disease of bone
Psoriasis
Rheumatoid arthritis
Skin cancer
Varicella zoster virus
Introduction to pharmacology
Drug administration and dosing regimens
Enzyme function
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug absorption and distribution
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Desensitization and tolerance
Pharmacodynamics: Agonist, partial agonist and antagonist
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid use disorder
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs

Transcript

Watch video only

Content Reviewers

Ventricular refers to the bottom chambers of the heart, the right and left ventricles, as opposed to the top chambers, the right and left atria. Tachycardia refers to a fast heart rate. Typically, a tachycardic, or fast, heart rate is considered anything above 100 beats per minute, or bpm. However, ventricular tachycardia is different than a fast heart rate from exercising, which is called sinus tachycardia.

Normally, the electrical signals that generate each heartbeat start in the right atrium at the sinus node, which is also known as the sinoatrial node, or the SA node. If the rate goes over 100 bpm and originates in the SA node, it’s considered sinus tachycardia, which is totally normal.

However, heartbeats can become abnormal if the electrical signals don’t start in the SA node, but start in the ventricles instead. Premature Ventricular Contractions, or PVCs, are single beats originating from the lower chambers. Any time there are more than three beats like this in a row, then it’s defined as ventricular tachycardia. Ventricular tachycardia, sometimes called V-tach, or VT, can cause the heart rate to rise above 100 beats per minute, which can be extremely dangerous and lead to sudden cardiac death.

Hold on, how can that happen? It’s not like while we exercise we’re risking sudden cardiac death, right? Well, even though we say tachycardia is anything above 100 beats per minute, most patients with ventricular tachycardia experience heart rates as high as 250 beats per minute. 250 beats per minute mean that the heart is beating over four times per second. When the chambers are pumping that fast, they don’t have enough time to even fill with blood, so the heart is furiously pumping out only tablespoons of blood to your body, and most importantly, to your brain, which is just not enough. If this happens, a person can have symptoms from not having enough perfusion to their tissues, such as chest pain, fainting, dizziness, or shortness of breath. It can even cause sudden death.

Now, there are essentially two ways an electrical signal can start in a ventricle: either the signal is focal, or it’s reentrant. Focal V-tach happens when a specific area of the ventricle has abnormal automaticity. The automaticity rate is the frequency at which a cell sends out a signal, so for the pacemaker cells in the SA node, the rate is between about 60 and 100 signals per minute, resulting in 60 to 100 beats per minute. Let’s just say 60 beats per minute, so one beat every second. Some specialized pacemaker cells in the ventricles also have this ability; they’re just usually a lot slower, making about 30 beats per minute, or one beat every two seconds. So, in most cases, the SA node fires signals off a lot faster, which sends electrical waves throughout the atria and ventricles. This doesn’t give the ventricular pacemaker cells a chance to ever have just two seconds of peace, which is what they need before they fire at a rate of 30 bpm.

For example, imagine all the other pacemaker cells stopped suddenly. After two seconds, the ventricular cells would initiate a signal, right? Now, if a certain area of ventricular tissue gets stressed or irritated in some way, the ventricular pacemaker cells might start firing at higher rates. They essentially flip roles with the SA node, firing so fast that the pacemaker cells in the SA node don’t get a chance to fire; at this point, the heartbeat is being driven by the ventricles. This stress might be triggered by: certain medications; illicit drugs, such as methamphetamine or cocaine; electrolyte imbalances; and ischemia to the ventricular muscle.

However, it’s more common for V-tach to be reentrant, as opposed to focal. So, let’s take a closer look at the cardiomyocytes, or heart muscles cells, instead of the pacemaker cells. These can be stressed in a similar way, which might change a couple of their properties, including how fast they relay, or conduct the signal to the next cell, and how long their refractory period is. Now, the refractory period is the period right after conducting a signal when the cells can’t conduct another signal.

All right, to help explain this, let’s say the myocardial tissue on side A conducts really fast, so the electrical signal zips through; however, it takes a long time to be able to conduct again. In other words, it has a long refractory period. The other side, or side B, is the exact opposite; it has slow conduction and a short refractory period. Now, this isn’t entirely unusual, since the heart can naturally have tissue with different properties. But let’s say that this tissue becomes damaged, and some of these cells actually die, like with a heart attack. Well, now you’ll get some scar tissue, which really can’t conduct the signal as well. Sometimes, this can create a sort of split pathway, where it goes around the scar and meets back up on the other side.

Under these conditions, it’s possible that a reentrant circuit develops. Okay, if one signal comes through, that’s fine. On side A, the wave makes it around first and goes on to the rest of the ventricle, and contracts the ventricle. It also starts up the other path, and sort of runs into the other, slower wave, which is called a unidirectional block.

Key Takeaways

Ventricular tachycardia is a type of tachycardia, or a rapid heartbeat that arises from improper electrical activity of the heart presenting as a rapid heart rhythm that starts in the ventricles. There are two main types of ventricular tachycardia: monomorphic, and polymorphic ventricular tachycardias.

In monomorphic ventricular tachycardia, all the beats look the same because the impulse is either being generated from increased automaticity of a single point in either the left or the right ventricle, or due to a reentry circuit within the ventricle. Polymorphic ventricular tachycardia, on the other hand, is most commonly caused by abnormalities of ventricular muscle repolarization. Ventricular tachycardia is a potentially life-threatening arrhythmia because it can cause low blood pressure and may lead to ventricular fibrillation, asystole, and sudden death. Ventricular tachycardia ranges between 100 and 250 bpm.